1. Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy
   Sanela Dozic et al, 2023, Cells CrossRef
2. Overexpression of Programmed Cell Death 1 Prevents Doxorubicin-Induced Apoptosis Through Autophagy Induction in H9c2 Cardiomyocytes
   Syu-ichi Kanno et al, 2022, Cardiovascular Toxicology CrossRef
3. Anthracycline Associated Disturbances of Cardiovascular Homeostasis
   Ashot Avagimyan et al, 2022, Current Problems in Cardiology CrossRef
4. Extracellular Vesicles Released after Doxorubicin Treatment in Rats Protect Cardiomyocytes from Oxidative Damage and Induce Pro-Inflammatory Gene Expression in Macrophages
   Chontida Yarana et al, 2022, International Journal of Molecular Sciences CrossRef
5. Early detection of anthracycline-induced cardiotoxicity
   Weimin Feng et al, 2025, Clinica Chimica Acta CrossRef
6. Mechanisms of Cardiovascular Toxicities Induced by Cancer Therapies and Promising Biomarkers for Their Prediction: A Scoping Review
   Tingting Yan et al, 2024, Heart, Lung and Circulation CrossRef
7. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods
   Ziyu Kuang et al, 2024, Current Treatment Options in Oncology CrossRef
8. Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity
   Nikša Drinković et al, 2024, Nanoscale CrossRef